2012
DOI: 10.1111/j.1747-0803.2012.00682.x
|View full text |Cite
|
Sign up to set email alerts
|

Induction of Atrial Fibrillation with Adenosine during a Transesophageal Electrophysiology Study to Risk Stratify a Patient with Asymptomatic Ventricular Preexcitation

Abstract: An asymptomatic adolescent male athlete was incidentally found to have ventricular preexcitation on electrocardiogram during a sports preparticipation physical. A transesophageal electrophysiology study (TEEPS) was performed after an exercise stress test failed to delineate the patient's risk of sudden cardiac death. The TEEPS was favored in this case over a transvenous electrophysiology study due to reduced invasiveness. The goal of the TEEPS was to place the patient into atrial fibrillation (AFib) and evalua… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 17 publications
0
1
0
1
Order By: Relevance
“…Среди кардиотонических ЛС частота ЛИФП достигает 23,3% для допамина [41,60], 18% -для добутамина [41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59] и 12% -для аденозина [22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40]. Известно, что прием антиаритмических ЛС способен также провоцировать развитие ЛИФП: пропафенона -в 6% случаев [67,79,80], амиодарона -в 9% [67][68][69][70][71][72] и флекаинида (не зарегистрирован в Российской Федерации для применения) -в 1,3% случаев [79,…”
Section: Drug-induced Atrial Fibrillation лекарственно-индуцированная...unclassified
“…Среди кардиотонических ЛС частота ЛИФП достигает 23,3% для допамина [41,60], 18% -для добутамина [41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59] и 12% -для аденозина [22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40]. Известно, что прием антиаритмических ЛС способен также провоцировать развитие ЛИФП: пропафенона -в 6% случаев [67,79,80], амиодарона -в 9% [67][68][69][70][71][72] и флекаинида (не зарегистрирован в Российской Федерации для применения) -в 1,3% случаев [79,…”
Section: Drug-induced Atrial Fibrillation лекарственно-индуцированная...unclassified
“…Therefore, the real refractory period of accessory pathway is less than 210 MS, suggesting high‐risk accessory pathway. Because the measurement of antegrade refractory period of accessory pathway is easily affected by atrial refractory period, some researchers believe that measuring the shortest RR interval of AF induced by intracardiac electrophysiology is a reliable index to predict high‐risk preexcitation patients, one literature reported the use of adenosine to increase the chance of inducing atrial fibrillation during TEEPS to enable risk stratification in asymptomatic patients with ventricular preexcitation(Hoyt et al., 2013b). Although this method is relatively effective, it also has the risk of causing atrial fibrillation and then developing into ventricular fibrillation.…”
Section: Figurementioning
confidence: 99%